Reuters logo
7 months ago
BRIEF-Neuroderm completes patient enrollment in Phase II trial of advanced Parkinson'S disease drug
December 22, 2016 / 12:18 PM / 7 months ago

BRIEF-Neuroderm completes patient enrollment in Phase II trial of advanced Parkinson'S disease drug

1 Min Read

Dec 22 (Reuters) - Neuroderm Ltd

* Neuroderm announces completion of patient enrollment and treatment in a Phase II trial of ND0612H for advanced Parkinson's disease

* Topline results from this trial are expected in Q1 of 2017. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below